ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,459,956, issued on Nov. 4, was assigned to Alcon Inc. (Fribourg, Switzerland).
"Heterobicyclic carboxamides and uses thereof" was invented by Mitchell A. deLong (Chapel Hill, N.C.), Jill M. Sturdivant (Chapel Hill, N.C.), Cynthia L. Lichorowic (Raleigh, N.C.) and Heeren M. Gordhan (Durham, N.C.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are heterobicyclic cyclopropanecarboxamide and heterobicyclic carboxamide compounds. In particular, provided herein are compounds that affect the function of kinases in a cell, and that are useful as therapeutic agents or with therapeutic agents. The compounds provided herein are useful in the treatmen...